Personalized, Value-based Care
How Avalon uses lab data and predictive analytics to reduce costs, align resources, and support equitable care.
Avalon’s Approach
Avalon delivers an integrated analytics engine that ties diagnostic values, treatment protocols, and real-world evidence across clinical conditions. Our platform:
- Stratifies risk by analyzing lab values
- Identifies inappropriate utilization and aligns treatment to evidence-based pathways
- Automates benefit decisions, reducing administrative burden through therapy-matching and prior authorization
- Visualizes performance through dashboards that track provider behavior, lab trends, and policy outcomes
These tools power proactive, equitable care while supporting scalable value-based strategies.
Proven Impact
Through Avalon’s data analysis to address high spend and care gaps across oncology and GLP-1 utilization, we found:
Oncology
43%
of NSCLC patients were receiving targeted drugs without evidence of genetic testing
70%
reduction in time-to-treatment by deploying NGS-first protocols and matching treatment to mutations
Cardiometabolic
Low-risk diabetics were
3x
more likely to receive GLP-1s than high-risk patients
Increase
in treatment access for highest-risk segment when Avalon’s risk stratification model used to rebalance therapy allocation
Key Capabilities Used
- Predictive Lab Intelligence & Risk Scoring
- Diagnostic & Therapy-Matching Analytics Engine
- Provider Performance & Utilization Dashboards
Impact
- Reduce total cost of care through smarter diagnostics and targeted therapy allocation
- Improved outcomes across cancer survival, cardiometabolic control, and hospitalization rates
- Enhanced equity with increased access for highest-risk patients
- Streamlined operations via automated prior authorization and lab policy alignment